Literature DB >> 2862163

Cobalamin inactivation decreases purine and methionine synthesis in cultured lymphoblasts.

G R Boss.   

Abstract

The megaloblastic anemia of cobalamin deficiency appears secondary to decreased methionine synthetase activity. Decreased activity of this enzyme should cause 5-methyltetrahydrofolate to accumulate intracellularly, and consequently, decrease purine and DNA synthesis; this is the basis of the "methylfolate trap" hypothesis of cobalamin deficiency. However, only some of the clinical and biochemical manifestations of cobalamin deficiency can be explained by the methylfolate trap. We investigated cobalamin deficiency by treating cultured human lymphoblasts with N2O since N2O inhibits methionine synthetase activity by inactivating cobalamin. We found that 4 h of N2O exposure reduced rates of methionine synthesis by 89%. Rates of purine synthesis were not significantly reduced by N2O when folate and methionine were present at 100 microM in the medium; however, at the physiologic methionine concentration of 10 microM, N2O decreased rates of purine synthesis by 33 and 57% in the presence of 100 microM folate and in the absence of folate, respectively. The dependency of rates of purine synthesis on methionine availability would be expected in cells with restricted methionine synthetic capacity because methionine is the immediate precursor of S-adenosylmethionine, a potent inhibitor of 5-methyltetrahydrofolate synthesis; methionine serves as a source of formate for purine synthesis; and rates of purine synthesis are dependent on the intracellular availability of essential amino acids. We conclude that cobalamin inactivation decreases purine synthesis by both methylfolate trapping and reduction of intracellular methionine synthesis.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2862163      PMCID: PMC423748          DOI: 10.1172/JCI111948

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  37 in total

1.  Responses to "physiologic" doses of folic acid in the megaloblastic anemias.

Authors:  R A MARSHALL; J H JANDL
Journal:  Arch Intern Med       Date:  1960-03

Review 2.  Interrelationships of vitamin B12 and folate in man.

Authors:  P F Nixon; J R Bertino
Journal:  Am J Med       Date:  1970-05       Impact factor: 4.965

3.  Methionine metabolism in mammals. Distribution of homocysteine between competing pathways.

Authors:  J D Finkelstein; J J Martin
Journal:  J Biol Chem       Date:  1984-08-10       Impact factor: 5.157

4.  Sulfur-containing amino acids in the plasma and urine of homocystinurics.

Authors:  T L Perry; S Hansen; L MacDougall; P D Warrington
Journal:  Clin Chim Acta       Date:  1967-03       Impact factor: 3.786

5.  Identification of 2-keto-4-methylthiobutyrate as an intermediate compound in methionine synthesis from 5'-methylthioadenosine.

Authors:  P S Backlund; C P Chang; R A Smith
Journal:  J Biol Chem       Date:  1982-04-25       Impact factor: 5.157

6.  Chronic cobalamin inactivation impairs folate polyglutamate synthesis in the rat.

Authors:  J Perry; I Chanarin; R Deacon; M Lumb
Journal:  J Clin Invest       Date:  1983-05       Impact factor: 14.808

7.  Hemolytic anemia and G6PD deficiency.

Authors:  A Yoshida
Journal:  Science       Date:  1973-02-09       Impact factor: 47.728

8.  Measurements of S-adenosylmethionine and L-homocysteine metabolism in cultured human lymphoid cells.

Authors:  D C German; C A Bloch; N M Kredich
Journal:  J Biol Chem       Date:  1983-09-25       Impact factor: 5.157

9.  Marrow cells from patients with untreated pernicious anaemia cannot use tetrahydrofolate normally.

Authors:  R Deacon; I Chanarin; J Perry; M Lumb
Journal:  Br J Haematol       Date:  1980-12       Impact factor: 6.998

10.  Decreased methionine synthesis in purine nucleoside-treated T and B lymphoblasts and reversal by homocysteine.

Authors:  G R Boss; R B Pilz
Journal:  J Clin Invest       Date:  1984-10       Impact factor: 14.808

View more
  5 in total

1.  Folate-responsive homocystinuria and megaloblastic anaemia in a female patient with functional methionine synthase deficiency (cblE disease).

Authors:  B Fowler; R B Schutgens; D S Rosenblatt; G P Smit; J Lindemans
Journal:  J Inherit Metab Dis       Date:  1997-11       Impact factor: 4.982

2.  Purine deoxynucleosides and adenosine dialdehyde decrease 5-amino-4-imidazolecarboxamide (Z-base)-dependent purine nucleotide synthesis in cultured T and B lymphoblasts.

Authors:  G R Boss
Journal:  Biochem J       Date:  1987-03-01       Impact factor: 3.857

3.  Methionine synthase is essential for cancer cell proliferation in physiological folate environments.

Authors:  Mark R Sullivan; Alicia M Darnell; Montana F Reilly; Tenzin Kunchok; Lena Joesch-Cohen; Daniel Rosenberg; Ahmed Ali; Matthew G Rees; Jennifer A Roth; Caroline A Lewis; Matthew G Vander Heiden
Journal:  Nat Metab       Date:  2021-11-18

4.  Erythroid dysplasia, megaloblastic anemia, and impaired lymphopoiesis arising from mitochondrial dysfunction.

Authors:  Michael L Chen; T Daniel Logan; Maryann L Hochberg; Suresh G Shelat; Xiang Yu; Gregory E Wilding; Wei Tan; Gregory C Kujoth; Tomas A Prolla; Mary A Selak; Mondira Kundu; Martin Carroll; James E Thompson
Journal:  Blood       Date:  2009-09-04       Impact factor: 22.113

Review 5.  Glyphosate, pathways to modern diseases II: Celiac sprue and gluten intolerance.

Authors:  Anthony Samsel; Stephanie Seneff
Journal:  Interdiscip Toxicol       Date:  2013-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.